Mallinckrodt announces appointment of dr. peter richardson, mrcp, as chief scientific officer

Dublin , jan. 12, 2023 /prnewswire/ -- mallinckrodt plc (nyse american: mnk) ("mallinckrodt" or the "company"), a global specialty pharmaceutical company, today announced that dr. peter richardson, b.med.sci., bm, bs, mrcp (uk) has been appointed executive vice president and chief scientific officer, effective january 12, 2023.
MNK Ratings Summary
MNK Quant Ranking